Blog
About

1
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      First detection and genome sequencing of SARS‐CoV‐2 in an infected cat in France

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          After its first description in Wuhan (China), SARS‐CoV‐2 the agent of coronavirus disease 2019 (COVID‐19) rapidly spread worldwide. Previous studies suggested that pets could be susceptible to SARS‐CoV‐2. Here, we investigated the putative infection by SARS‐CoV‐2 in 22 cats and 11 dogs from owners previously infected or suspected of being infected by SARS‐CoV‐2. For each animal, rectal, nasopharyngeal swabs and serum were taken. Swabs were submitted to RT‐qPCR assays targeting 2 genes of SARS‐CoV‐2.

          All dogs were tested SARS‐CoV‐2 negative. One cat was tested positive by RT‐qPCR on rectal swab. Nasopharyngeal swabs from this animal were tested negative. This cat showed mild respiratory and digestive signs. Serological analysis confirms the presence of antibodies against the SARS‐CoV‐2 in the both serum samples taken 10 days apart. Genome sequence analysis revealed that the cat SARS‐CoV‐2 belongs to the phylogenetic clade A2a like most of the French human SARS‐CoV‐2.

          This study reports for the first time the natural infection of a cat in France (near Paris) probably through their owners. There is currently no evidence that cats can spread COVID‐19 and owners should not abandon their pets or compromise their welfare.

          Related collections

          Author and article information

          Contributors
          Sophie.Lepoder@vet-alfort.fr
          Journal
          Transbound Emerg Dis
          Transbound Emerg Dis
          10.1111/(ISSN)1865-1682
          TBED
          Transboundary and Emerging Diseases
          John Wiley and Sons Inc. (Hoboken )
          1865-1674
          1865-1682
          05 June 2020
          Affiliations
          [ 1 ] UMR VIROLOGIE INRAE Ecole Nationale Vétérinaire d’Alfort ANSES Laboratoire de santé animale Université Paris‐Est Maisons‐Alfort 94700 France
          [ 2 ] Institut Pasteur Laboratory for Urgent Response to Biological Threats, Environment and Infectious Risk Unit Paris France
          [ 3 ] Institut Pasteur The OIE Collaborating Centre for Detection and Identification in Humans of Emerging Animal Pathogens Paris France
          [ 4 ] Clinique vétérinaire Savigny sur Orge France
          [ 5 ] CHUVA Ecole Nationale Vétérinaire d’Alfort Université Paris‐Est Maisons‐Alfort 94700 France
          [ 6 ] IDVET 310 rue Louis Pasteur 34790 Grabels France
          Author notes
          [* ] Corresponding author

          Sophie Le Poder

          Email: Sophie.Lepoder@ 123456vet-alfort.fr

          Article
          TBED13659
          10.1111/tbed.13659
          7300955
          32500944
          This article is protected by copyright. All rights reserved.

          This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

          Page count
          Figures: 0, Tables: 0, Pages: 12, Words: 539
          Product
          Categories
          Rapid Communication
          Rapid Communication
          Custom metadata
          2.0
          accepted-manuscript
          Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.4 mode:remove_FC converted:18.06.2020

          Infectious disease & Microbiology

          elisa, luminex, next‐generation sequencing, sars‐cov‐2, pets, cats

          Comments

          Comment on this article